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  ABSTRACT 
  Wasp venoms contain a number of pharmacologically active biomolecules, undertaking a wide range of func-
tions necessary for the wasp’s survival. We puriﬁ  ed and characterized a novel bioactive peptide (vespin) from 
the venoms of   Vespa magniﬁ  ca   (Smith) wasps with unique primary structure. Its amino acid sequence was 
determined to be CYQRRVAITAGGLKHRLMSSLIIIIIIRINYLRDNSVIILESSY. It has 44 residues including 
15 leucines or isoleucines (32%) in the sequence. Vespin showed contractile activity on isolated ileum smooth 
muscle. The cDNA encoding vespin precursor was cloned from the cDNA library of the venomous glands. 
The precursor consists of 67 amino acid residues including the predicted signal peptide and mature vespin. A 
di-basic enzymatic processing site (-KR-) is located between the signal peptide and the mature peptide. Vespin 
did not show similarity with any known proteins or peptides by BLAST search, suggesting it is a novel bioac-
tive peptide from wasp venoms.   
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 INTRODUCTION 
  Over the past few decades the venoms of arthropods, 
especially the wasp venom, have attracted considerable 
interest as a potential source of bioactive substances. The 
members of the Vespidae family include hornets (genera 
  Vespa   and   Dolichovespula  ), yellow jackets (genus   Vespula ) 
and paper wasps (genus   Polistes  ). They all possess highly 
toxic venoms, which are a complex mixture of amines, 
small peptides and high molecular weight proteins, such 
as enzymes, allergens and toxins (  Habermann, 1972  ; 
  Nakajima, 1984  ;   Yang et al, 2008  ;   de Graaf et al, 2009  ). 
As a predator, the venoms from these stinging wasps are 
important weapons both in the defense of the colony and 
the capture of the prey. The wasp inserts and withdraws 
its sting much easier than that of a bee because of its 
smooth outer lining, while a bee’s sting has a barbed 
outer sheath appearing like a ﬁ  sh hook, which is easy to 
insert but difﬁ  cult to extract. Thus, the multi-sting capac-
ity of the wasp bestows it a more aggressive nature. 
  A single wasp sting could kill or paralyze their pray insects 
instantly. The clinical symptoms induced in humans include 
local reactions (such as pain, wheal, edema and swell-
ing), immunological reactions usually leading to anaphy-
laxis with subsequent anaphylactic shock, and systemic 
toxic reactions caused by large doses of venom, resulting 
in hemolysis, coagulopathy, rhabdomyolysis, acute renal 
failure, hepatotoxicity, aortic thrombosis and cerebral inf-
arction (  Evans and Summer, 1986  ;   Sakhuja et al, 1988  ; 
  Korman et al, 1990  ;   Watemberg et al, 1995  ;   Chao and Lee, 
1999  ;   Chen et al, 2004  ). Several families of peptides or pro-
teins from wasp venoms have been proven to contribute to 
some of these clinical symptoms, such as phospholipase 
A1 platelet activator (  Yang et al, 2008  ), serine protein-
ases, antigen 5-related (Ag 5) proteins and hyaluronidases 
( Nakajima,  1984 ).  Most of the molecular mechanisms of 
clinical symptoms induced by wasp venoms are unknown. 
Thus it is critical to identify more bioactive components 
from wasp venoms and to understand their mechanisms of 
action. In this study, we puriﬁ  ed and characterized a novel 44
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was repeated ﬁ  ve times. All animal experiments were con-
ducted in line with the local ethical guidelines of working 
with animals. 
   SMART  cDNA  synthesis 
  This was done as previously described, using a SMART  TM  
PCR cDNA synthesis kit (Clontech, Palo Alto, CA) (  Xu 
et al, 2006a  ;   Yu et al, 2007  ). Venomous glands (n=30) were 
dissected from   V .   magniﬁ  ca.   Total RNA was extracted 
using TRIzol (Life Technologies, Ltd). The ﬁ  rst  strand 
was synthesized with the cDNA 3’ SMART CDS Primer 
II A, 5’AAGCAGTGGTATCAACGCAGAGTACT (30) 
YZ3’ (Y=A, G or C; Z=A, C, G or T), and SMART II A 
oligonucleotide, 5’AAGCAGTGGTATCAACGCAGAG-
TACGCGGG3’. The second strand was ampliﬁ  ed by using 
Advantage polymerase and 5’ PCR primer II A, 5’AAG-
CAGTGGTATCAACGCAGAGT3’. Finally, the PCR prod-
ucts were cloned into pGEM®-T Easy vector (Promega, 
Madison, WI). 
   cDNA  cloning 
  The cDNA synthesized by SMART  TM   techniques was used as 
template library to screen cDNA clones. Two oligonucleotide 
primers, S  1   (5’TG(T/C)TA(T/C)GA(A/G)AG(A/G)AG(A/G)
GT(A/T/C/G)GC(A/T/C/G)AT3’) (in the sense direction), a 
degenerate primer designed according to the sequence deter-
mined by Edman degradation, and primer II A (in the anti-
sense direction) used in the previous step were used in PCR, 
which was conducted using the Advantage polymerase from 
Clontech (Palo Alto, CA) as follows: 2min at 94  o  C, then 30 
cycles of 10sec at 92  o  C, 30sec at 50  o  C and 40sec at 72  o C. 
DNA sequencing was performed in an Applied Biosystems 
DNA sequencer (Model ABI PRISM 377). 
   Synthetic  peptide 
  The peptide used for bioassays was synthesized by GL Bio-
chem (Shanghai) Ltd (Shanghai, China) and analyzed by 
HPLC and mass spectrometry to conﬁ  rm purity which was 
greater than 98%. 
    RESULTS 
  Peptide  Puriﬁ  cation 
  As reported in our previous work, the wasp venom was 
fractionated into ﬁ  ve peaks by Sephadex G-50 gel ﬁ  ltration. 
Fraction III contains activity to contract isolated smooth 
muscle. Fraction III was applied to a CM-Sephadex C-25 
ion- exchange column and 12 further fractions were eluted 
(  Xu et al, 2006a  ;   Yu et al, 2007  ). The smooth muscle con-
tractile activity was found in fraction XII. After ﬁ  nal puri-
ﬁ  cation by C  18   RP-HPLC, the fraction XII was subdivided 
into more than 20 fractions. The eluted peak at 34min with 
an acetonitrile concentration of 45% (labeled with an arrow 
in   Figure 1  ) contained the activity producing contraction of 
the isolated smooth muscles. 
     Structural  Characterization 
 Puriﬁ  ed peptide, named vespin, was subjected to amino 
acid sequence analysis by automated Edman degrada-
tion, which produced the following amino acid sequence: 
CYQRRVAITAGGLKHRLMSSLIIIIIIRINYLRDNSVII-
LESSY. The mass spectrometry gave an observed mass 
peptide from the wasp venom, which is able to induce con-
traction of smooth muscle.    
 MATERIALS AND  METHODS 
  Wasp  venom 
 Wasps  ( V . magniﬁ  ca  ) were collected in Yunnan Province, 
China, and the venom was extracted according to our pre-
viously reported methods (  Xu et al, 2006a  ;   Yu et al, 2007  ). 
Brieﬂ  y, wasps were stimulated by alternative current (6V) 
for 6-10sec. This led to the secretion of venom, which was 
collected onto a clean glass plate (50x50cm). The venom was 
immediately collected and stored at -20  o  C until further use.    
 Peptide  puriﬁ  cation 
  The wasp venom was dissolved in 0.1M phosphate buffered 
saline, pH 6.0 (PBS). The sample was applied to a Sepha-
dex G-50 (Superﬁ  ne, Amersham Biosciences, 2.6x100cm) 
gel ﬁ  ltration column equilibrated with 0.1M PBS as previ-
ously reported (  Xu et al, 2006a  ;   Yu et al, 2007  ). Elution was 
performed with the same buffer; 3.0ml fractions were col-
lected and the elutent was monitored at 280nm. The peaks 
that demonstrated activity on our smooth muscle assay were 
further subjected to a CM-Sephadex C-25 ion exchange col-
umn (Amersham Biosciences, 2.6x50cm), equilibrated with 
0.1M PBS. Elution was achieved with a linear NaCl gradi-
ent in 0.1M PBS, and the elutent was monitored at 215nm. 
The ﬁ  nal puriﬁ  cation of peptide was performed using C  18  
reverse phase high-performance liquid chromatography 
(RP-HPLC, Hypersil BDS C  18  , 30x0.46cm), and the elutent 
was monitored at 215nm. 
   Structural  analysis 
  The eluted fraction containing smooth muscle contractile 
activity from RP-HPLC was subjected to mass analysis 
by a matrix-assisted laser desorption ionization time-of-
ﬂ   ight mass spectrometer (MALDI-TOF-MS) AXIMA 
CFR (Kratos Analytical) in positive ion and linear mode. 
The operation parameters were as follows: The ion accel-
eration voltage was 20kV , the accumulating time of a single 
scanning was 50sec, and the polypeptide mass standard 
(Kratos Analytical) served as external controls. The accu-
racy of mass determinations was within 0.1%. The complete 
amino acid sequences of antimicrobial peptides were deter-
mined by Edman degradation in an Applied Biosystems 
pulsed liquid-phase sequencer (Model 491).    
  Smooth muscle contraction assay 
  As previously described (  Liang et al, 2006  ), the contrac-
tile activity of isolated guinea pig ileum was tested. About 
10cm of the distal ileum of male or female guinea pigs 
(150-250gm body weight) was isolated immediately after 
death and kept in Tyrode solution (137mM NaCl, 2.7mM 
KCl, 1.36mM CaCl  2  , 0.49mM MgCl  2  , 0.36mM NaH  2 PO 4 , 
11.9mM NaHCO  3  , 5.04mM D-glucose). Cut segments with 
2 cm length of the isolated ileum were mounted isotonically, 
under 1-g load, in a 5ml muscle bath containing Tyrode 
solution maintained at 37  o  C and bubbled with air. Differ-
ent concentrations of test sample were added into the organ 
bath. Tension was recorded and analyzed by PcLab software 
package (Beijing Microsignalstar Technology Development 
Co Ltd, Beijing, China). Each dosage of the tested sample 45
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concentration-dependent contractile effects on isolated 
guinea pig ileum. 
      DISCUSSION 
  Several families of bioactive peptides have been iden-
tiﬁ  ed in wasp venoms. These peptides are bradykinin-
like peptides, chemotactic peptides and mastoparans 
(  Higashijima et al, 1979  ;   Piek, 1984  ). Local or systemic 
reactions may come from these biologically active pep-
tides. These major actions include, limited   in vitro   anti-
microbial effects (  Xu et al, 2006b  ) and inﬂ  ammation 
induction by lysing cell membrane or stimulating mast 
cell degranulation, histamine release and consequent 
vasodilatation, and increasing neutrophils and T helper 
cells chemotaxis (  Argiolas and Pisano, 1985  ;   Nakajima 
et al, 1986  ;   Hancock et al, 1995  ;   Wu and Hancock, 1999  ). 
All of these effects are related with cardiovascular sys-
tem, nervous system and immunological system of mam-
mals, including humans. 
  In the current study we puriﬁ   ed and characterized a 
novel bioactive peptide (vespin) containing 44 amino 
acid residues. It exerts contractile function on isolated 
ileum smooth muscle. Bradykinin-like peptides in wasp 
venoms have also function to induce contraction of 
ileum smooth muscle. They exert their bioactivity by 
interacting with bradykinin receptors. All members of 
bradykinin-like peptides share conserved –PPGF(T/S)
P(F/L)- structure at their C-terminus (  Liu et al, 2008  ). 
of 5077.3 that matches well with the predicted mass of 
5077.1. Vespin is composed of 44 amino acid residues 
including 6 basic (K or R) and 2 acidic (D or E) amino 
acid residues. This peptide is characterized by a single half-
cysteine positioned at the N-terminus and 15 leucines or 
isoleucines. 
   cDNA  cloning 
  Upon screening of a venomous gland cDNA library, sev-
eral clones containing inserts of around 520 base pairs were 
identiﬁ  ed and isolated. Both strands of these clones were 
sequenced. The complete nucleotide sequence and deduced 
amino acid sequence of the representative clone is presented 
in   Figure 2  . It was found to contain a coding region of 
201 nucleotides, which encodes the precursor of vespin. The 
encoded amino acid sequence corresponds to a polypep-
tide precursor of 57 amino acid residues, which included 
the predicted signal peptide and a mature vespin. The 
deduced amino acid sequence was identical to the amino 
acid sequence determined by Edman degradation sequenc-
ing. BLAST searches did not return any peptides or proteins 
similar to vespin. 
          Myotropic effects on isolated guinea pig ileum 
  The contractile activity of the vespin was evaluated in 
isolated guinea pig ileum in aerated Tyrode’s solution at 
37  o  C. 15nM vespin was found to induce maximal ileum 
contraction (Data not shown). 0.5, 1.0, 2.0, 4.0, and 8.0nM 
vespin was added to a 5ml organ bath at 10min intervals 
serially. As shown in   Figure 3  , vespin was found to elicit 
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  Figure 1.      Puriﬁ  cation of vespin from   V .   magniﬁ  ca   venoms. After Sephadex G-50 gel ﬁ  ltration and CM-Sephadex C-25 
ion-exchange column (  Xu et al, 2006a  ;   Yu et al, 2007  ), fraction XII from CM-Sephadex C-25 column was found to exert 
contractile activity on smooth muscle. Fraction XII was applied to a Hypersil BDS C  18   RP-HPLC column (30x0.46cm) 
equilibrated with 0.1% (v/v) triﬂ  uoroacetic acid/water. The elution was performed with the indicated gradient of ace-
tonitrile at a ﬂ  ow rate of 0.7ml/min, and fractions were tested for smooth muscle contractile activity. The puriﬁ  ed vespin 
is labeled with an arrow.   46
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work is ongoing in our laboratory to identify the possible 
bioactivities of vespin and the corresponding molecular 
mechanisms. 
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No such structure was found in the sequence of vespin, 
suggesting that vespin does not belong to the bradykinin-
like peptide family. 
   CONCLUSIONS 
  The primary focus of the current work was the puriﬁ  cation 
and characterization of this peptide with unique primary 
structure from the wasp venoms, which was able to induce 
contraction of isolated ileum smooth muscles. Further 
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  Figure 2.        The nucleotide sequences encoding vespin from   V . magniﬁ  ca   and the deduced amino acid sequence of the pre-
cursor polypeptide. The sequence of mature vespin peptide is underlined. The bar (-) indicates the stop condon.   
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  Figure 3.        Concentration-response curves of vespin on isolated guinea pig ileum. The ileum was stimulated with increas-
ing concentrations of vespin, previously incubated for 10min, at 30  o  C, with 1x Tyrode solution. Each point represents 
the mean ± S.E.M. of ﬁ  ve different experiments. The 100% contractile activity was the contractile ability of the ileum 
induced by 15nM vespin.   47
©The Authors | Journal of Venom Research | 2010 | Vol 1 | 43-47| OPEN ACCESS
  Liu X, You D, Chen L, Wang X, Zhang K and Lai R. 2008. A novel 
bradykinin-like peptide from skin secretions of the frog,   Rana 
nigrovittata  . J Pept Sci, 14, 626-630. 
  Nakajima T. 1984. Biochemistry of vespid venoms, in: Tu AT (Ed), 
  Handbook of Natural Toxins  . Marcel Dekker, New York, USA, 
pp 109-133. 
  Nakajima T, Uzu S, Wakamatsu K et al. 1986. Amphiphilic peptides 
in wasp venom. Biopolymers, 25(Suppl), S115-121. 
  Piek T. 1984. Pharmacology of hymenoptera venom, in: Tu AD 
(Ed),   Handbook of Natural Toxins  . Marcel Dekker, New York, 
USA, Vol 2, pp 135-185. 
  Sakhuja V , Bhalla A, Pereira BJ, Kapoor MM, Bhusnurmath SR 
and Chugh KS. 1988. Acute renal failure following multiple 
hornet stings. Nephron, 49, 319-321. 
  Watemberg N, Weizman Z, Shahak E, Aviram M and Maor E. 1995. 
Fatal multiple organ failure following massive hornet stings. J 
Toxicol Clin Toxicol, 33, 471-474. 
  Wu M and Hancock RE. 1999. Interaction of the cyclic antimicro-
bial cationic peptide bectenecin with the outer and cytoplasmic 
membrane. J Biol Chem, 274, 29-35. 
  Xu X, Li J, Lu Q, Yang H, Zhang Y and Lai R. 2006a. Two families 
of antimicrobial peptides from wasp (  Vespa magniﬁ  ca )  venom. 
Toxicon, 47, 249-253. 
  Xu X, Yang H, Yu H, Li J and Lai R. 2006b. The mastoparanogen 
from wasp. Peptides, 27, 3053-3057. 
  Yang H, Xu X, Ma D, Zhang K and Lai R. 2008. A phospholipase 
A1 platelet activator from the wasp venom of   Vespa magniﬁ  ca  
(Smith). Toxicon, 51, 289-296. 
  Yu H, Yang H, Ma D et al. 2007. Vespid chemotactic peptide 
precursor from the wasp,   Vespa magniﬁ  ca   (Smith). Toxicon, 50, 
377-382.       
  REFERENCES 
  Argiolas A and Pisano JJ. 1985. Bombolitins, a new class of mast 
cell degranulating peptides from the venom of the bumblebee 
  Megabombus pennsylvanicus  . J Biol Chem, 260, 1437-1444. 
  Chao SC and Lee YY. 1999. Acute rhabdomyolysis and intravas-
cular hymolysis following extensive wasp stings. Int J Dermatol, 
38,135-137. 
  Chen DM, Lee PT, Chou KJ et al. 2004. Descending aortic throm-
bosis and cerebral infarction after massive wasp stings. Am J 
Med, 116, 567-569. 
  Evans R and Summers S. 1986. Clinical aspects of Hymenoptera 
sensitivity, in: Levine MI and Lockey RF (Eds),   American Acad-
emy of Allergy and Immunology ,   Monography on insect allergy , 
Lambert Associates, Pittsburgh, USA, pp 23-28. 
  De Graaf DC, Alerts M, Danneels E and Devreese B. 2009. 
Bee, wasp and ant venomics pave the way for a component-
resolved diagnosis of sting allergy. J Proteomics, 72, 145-154. 
  Habermann E. 1972. Bee and wasp venoms. Science, 177, 314-322. 
  Hancock RE, Falla T and Brown M. 1995. Cationic bactericidal 
peptides. Adv Microb Physiol, 37, 135-175. 
  Higashijima T, Inubushi T, Ueno T and Miyazawa T. 1979. NMR 
saturation transfer and line shape analyses of cyclic tetradepsipep-
tide AM toxin II: conformational equilibrium with very unequal 
populations. FEBS Lett, 105, 337-340. 
  Korman SH, Jabbour S and Harari MD. 1990. Mutiple hornet 
(  Vespa orientalis  ) stings with fatal outcome in a child. J Paediatr 
Child Health, 26, 283-285. 
  Liang J, Han Y, Li J, Xu X, Rees HH and Lai R. 2006. A novel 
bradykinin-like peptide from skin secretions of rufous-spotted 
torrent frog,   Amolops loloensis  . Peptides, 27, 2683-2687. 